Literature DB >> 7065115

Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants.

J Sturgess, J Imrie.   

Abstract

The development of the tracheal submucosal glands has been determined quantitatively in 22 infants with cystic fibrosis and in 25 control infants, all under 4 months of age. In cross-sections of normal trachea significant relationships were found between postconceptional age (PCA) and gland area (P less than 0.001), submucosal area (P less than 0.02), tracheal airway diameter (P less than 0.05), and acinar diameter (P less than 0.001). In infants with cystic fibrosis the pattern of development was similar to that of the control infants. No statistically significant differences were found between three subgroups of infants with cystic fibrosis, which included those with meconium ileus with no lung infection, those with meconium ileus with lung infection, and those with lung infection and no history of meconium ileus. The normal pattern of development of tracheal submucosal glands in infants with cystic fibrosis was in contrast to the deficiency of normal maturation seen in the exocrine pancreas of these infants. The lumen fraction, an index of dilatation of acinar lumina, showed no significant relationship with PCA in either the control group or the group with cystic fibrosis. However, statistically significant dilatation of acini was observed in the tracheal submucosal glands of infants with cystic fibrosis (0.14, P less than 0.005).

Entities:  

Mesh:

Year:  1982        PMID: 7065115      PMCID: PMC1916229     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Cystic fibrosis of the pancreas. Morphologic findings in infants with and without diagnostic pancreatic lesions.

Authors:  E H Oppenheimer; J R Esterly
Journal:  Arch Pathol       Date:  1973-09

2.  A morphometric study of bronchial and bronchiolar walls in children.

Authors:  K Matsuba; W M Thurlbeck
Journal:  Am Rev Respir Dis       Date:  1972-06

3.  Secretory activity of the human bronchial mucous glands in vitro.

Authors:  J Sturgess; L Reid
Journal:  Exp Mol Pathol       Date:  1972-06       Impact factor: 3.362

4.  Observations in cystic fibrosis of the pancreas. 3. Pulmonary lesions.

Authors:  J R Esterly; E H Oppenheimer
Journal:  Johns Hopkins Med J       Date:  1968-02

5.  Mucous gland hypertrophy in babies and children aged 15 years or less.

Authors:  W E Field
Journal:  Br J Dis Chest       Date:  1968-01

Review 6.  Research in cystic fibrosis (second of three parts).

Authors:  P A di Sant'Agnese; P B Davis
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

7.  Bronchial mucus gland hypertrophy: its relation to symptoms and environment.

Authors:  W E Field; E N Davey; L Reid; F J Roe
Journal:  Br J Dis Chest       Date:  1966-04

8.  Adult chronic bronchitis. Morphology, histochemistry and vascularisation of the bronchial mucous glands.

Authors:  R De Haller; L Reid
Journal:  Med Thorac       Date:  1965

9.  The bronchial mucous glands--their hypertrophy and change in intracellular mucus.

Authors:  L Reid; R de Haller
Journal:  Bibl Paediatr       Date:  1967

10.  The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups.

Authors:  C W Bedrossian; S D Greenberg; D B Singer; J J Hansen; H S Rosenberg
Journal:  Hum Pathol       Date:  1976-03       Impact factor: 3.466

View more
  31 in total

1.  Human bronchial epithelial cells differentiate to 3D glandular acini on basement membrane matrix.

Authors:  Xiaofang Wu; Jennifer R Peters-Hall; Sumit Bose; Maria T Peña; Mary C Rose
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

2.  ClC-5 chloride channel alters expression of the epithelial sodium channel (ENaC).

Authors:  L Mo; N K Wills
Journal:  J Membr Biol       Date:  2004-11       Impact factor: 1.843

3.  Characterizing mucous cell remodeling in cystic fibrosis: relationship to neutrophils.

Authors:  Steven R Hays; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2006-08-17       Impact factor: 21.405

4.  Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways.

Authors:  K B Adler; D D Hendley; G S Davis
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

Review 5.  Gene therapy for cystic fibrosis: challenges and future directions.

Authors:  J M Wilson
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  AJRCCM: 100-Year Anniversary. Progress along the Pathway of Discovery Leading to Treatment and Cure of Cystic Fibrosis.

Authors:  Bonnie W Ramsey; Michael J Welsh
Journal:  Am J Respir Crit Care Med       Date:  2017-05-01       Impact factor: 21.405

7.  Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children.

Authors:  David K Meyerholz; David A Stoltz; Eman Namati; Shyam Ramachandran; Alejandro A Pezzulo; Amanda R Smith; Michael V Rector; Melissa J Suter; Simon Kao; Geoffrey McLennan; Guillermo J Tearney; Joseph Zabner; Paul B McCray; Michael J Welsh
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

8.  Fluid transport across cultures of human tracheal glands is altered in cystic fibrosis.

Authors:  C Jiang; W E Finkbeiner; J H Widdicombe; S S Miller
Journal:  J Physiol       Date:  1997-06-15       Impact factor: 5.182

9.  Development of an airway mucus defect in the cystic fibrosis rat.

Authors:  Susan E Birket; Joy M Davis; Courtney M Fernandez; Katherine L Tuggle; Ashley M Oden; Kengyeh K Chu; Guillermo J Tearney; Michelle V Fanucchi; Eric J Sorscher; Steven M Rowe
Journal:  JCI Insight       Date:  2018-01-11

Review 10.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.